Oncology Practice Management seeks to offer process solutions for all members of the cancer care team—medical, surgical, and radiation oncologists, as well as executives, administrators, and coders/billers.

Featured Articles

Symptom Management

Updated ASCO Guidelines Reiterate the Importance of Geriatric Assessment in Older Patients with Cancer

The American Society of Clinical Oncology (ASCO) has issued an update to its guidelines for the practical assessment and management of vulnerabilities in patients aged ≥65 years receiving systemic cancer treatment. The new recommendations, published in the Journal of Clinical Oncology, build on the Society’s previous guidance, published in 2018.

Continue Reading
Biosimilars

Generic and Biosimilar Drugs Generate $408 Billion in Savings for America’s Patients and Healthcare System in 2022

Washington, DC—On September 6, 2023, the Association for Accessible Medicines, the leading trade association for generic and biosimilar manufacturers, released its 2023 U.S. Generic & Biosimilar Medicines Savings Report highlighting the value of generic and biosimilar medicines.

Continue Reading
Pancreatic Cancer

Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients

Philadelphia, PA—Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Continue Reading

Sanjay Juneja, MD, on the Approval of ORSERDU™

Dr Sanjay Juneja, medical oncologist and hematologist, and Chief of Oncology at Baton Rouge General Hospital–Mary Bird Perkins Cancer Center in Baton Rouge, LA, also known as “The Onc Doc,” is a well-known healthcare influencer. In the video above, Dr Juneja provides his perspectives on key efficacy and safety data from the EMERALD trial, the importance of testing for ESR1 mutations, and what the approval of ORSERDU (elacestrant) means for patients.

View Video

Video Library

2023 PSS Guide Spotlight

Amgen Assist 360/FIRST STEP Program

Amgen offers assistance to patients through Amgen Assist 360, Amgen SupportPlus Co-Pay Program, and the Amgen Safety Net Foundation.

Read More
AstraZeneca Access 360/AZ&Me Prescription Savings Program

AstraZeneca, through its Access 360 and AZ&Me programs, offers a range of patient assistance to help streamline access and reimbursement for select AstraZeneca medicines.

Read More
Pfizer Oncology Together

Pfizer offers Pfizer Oncology Together, a patient support program to help patients access their prescribed Pfizer Oncology medications, identify financial assistance options, and connect patients to a dedicated Care Champion.

Read More
The 2023 Guide to Patient Support Services

The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2022.

VIEW ALL 2023 PROFILES